论文部分内容阅读
乳腺癌治疗后持续性疼痛(PPBCT)是一种常见的不良反应,主要是神经病理性的疼痛,发生率高达50%。爱丁堡大学进行了一项以问卷调查为基础的横断面研究,主要是研究存在PPBCT的乳腺癌患者的情绪特点及相关危险因素和疼痛严重性。
Persistent pain after breast cancer treatment (PPBCT) is a common adverse reaction, mainly neuropathic pain, the incidence of up to 50%. A cross-sectional questionnaire-based cross-sectional study was conducted at the University of Edinburgh to study the emotional characteristics and associated risk factors and pain severity of breast cancer patients with PPBCT.